SEC Form 4 · accession 0001192482-19-000033
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Ryan David Lake
Officer — Chief Financial Officer
Period of report
Jan 18, 2019
Accepted (ET)
Jan 23, 2019 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 18, 2019 | A | 11,264 | $0.00 | A | 24,285 | D | |
| Common StockF2 | Jan 20, 2019 | A | 5,750 | — | A | 30,035 | D | |
| Common StockF3 | Jan 20, 2019 | F | 1,880 | $7.99 | D | 28,155 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F4 | $7.99 | Jan 18, 2019 | A | 53,859 | A | — | Jan 18, 2029 | Common Stock | 53,859 | 53,859 | D |
Explanation of responses
- F1All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning January 18, 2020, subject to continued employment with the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date.
- F2On January 20, 2019, the Compensation Committee of the Board of Directors of the Issuer determined that performance-vesting criteria were met with regard to 5,750 performance-based restricted stock units granted in a prior year, which were converted into 5,750 shares of common stock on a one-for-one basis.
- F3Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
- F4The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued employment with the Company.